These three companies have track records that should please investors.
The dividend is just one reason to buy these stocks.
A double beat on the latest quarterly results and raised guidance made investors happy.
Stocks that traded heavily or had substantial price changes on Tuesday: Novartis, Danaher rise; Nucor, Cadence Design Systems fall
NVS earnings call for the period ending March 31, 2024.
These income stocks look like good options at current levels.
Think globally with this high-yielding ETF.
Stocks that traded heavily or had substantial price changes on Thursday: Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise
Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster...